BRAF and neoplasm: The prevalence of BRAF-mutated cases among soft-tissue neoplasms is tumor-specific, estimated as high as 15–20% for malignant peripheral nerve sheath tumors [4] and as low as 0.5–9% for undifferentiated sarcomas [5, 6].